MedTrace Logo

Development and Validation of a Tumour Oxygenation Monitoring Probe

NCT03982355 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

Laboratory based study in which novel tissue oxygenation probe with the potential provide novel means for assessing response to cancer treatment will be developed and validated.

Conditions

Interventions

DEVICE

DRS probe

The Oxygenation measurements of the novel diffuse reflectance spectroscopy probe

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Ara Darzi · Imperial College London

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-09
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03982355 on ClinicalTrials.gov